Description / Application
Acadesine is a 1-ribosylimidazolecarboxamide in which the carboxamide group is situated at position 4 of the imidazole ring, which is further substituted at position 5 by an amino group. A purine nucleoside analogue and activator of AMP-activated protein kinase, it is is used for the treatment of acute lymphoblastic leukemia and is reported to have cardioprotective effects. It has a role as an antineoplastic agent and a platelet aggregation inhibitor. It is an aminoimidazole, a 1-ribosylimidazolecarboxamide and a nucleoside analogue.
Identities
| Alternative Name | N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide; 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside; 5-Amino-1-beta-D-ribofuranosyl-1H-imidazole-4-carboxamide; 5-Amino-4-imidazole carboxamide riboside; AICAR, Acadesine, Arasine, GP 1-110, NSC 105823 |
|---|---|
| Molecular Formula | C9H14N4O5 |
| Molecular Weight | 258.23 |
| MFCD | MFCD00869751 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315;H319;H335 |
| Precautionary Statements | P261;P264;P271;P280;P302+P352;P304+P340;P305+P351+P338;P312;P321;P332+P313;P337+P313;P362;P403+P233;P405;P501 |